Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04933_nanopub.RACqVsfLHfwuzGGfD6MAKXoLoOej8PAokawTlN4U0WHkg#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB04933 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04933 label "Eritoran [drugbank:DB04933]" assertion.
- drugbank:DB04933 seeAlso DB04933 assertion.
- drugbank:DB04933 identifier "drugbank:DB04933" assertion.
- drugbank:DB04933 description "Eritoran is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis." assertion.
- drugbank:DB04933 title "Eritoran" assertion.
- drugbank:DB04933 bio2rdf_vocabulary:identifier "DB04933" assertion.
- drugbank:DB04933 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04933 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04933" assertion.
- drugbank:DB04933 bio2rdf_vocabulary:x-identifiers.org DB04933 assertion.
- drugbank:DB04933 drugbank_vocabulary:drugbank-id "DB04933" assertion.
- drugbank:DB04933 drugbank_vocabulary:x-cas cas:185954-98-7 assertion.
- drugbank:DB04933 drugbank_vocabulary:x-chebi chebi:46692 assertion.
- drugbank:DB04933 drugbank_vocabulary:x-kegg kegg:D04043 assertion.